0001991732-23-000002.txt : 20231120 0001991732-23-000002.hdr.sgml : 20231120 20231120125740 ACCESSION NUMBER: 0001991732-23-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 EFFECTIVENESS DATE: 20231120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cantai Therapeutics, Inc. CENTRAL INDEX KEY: 0001991732 IRS NUMBER: 933026358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-497690 FILM NUMBER: 231422039 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPIA STATE: PA ZIP: 19104 BUSINESS PHONE: 603-996-1218 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPIA STATE: PA ZIP: 19104 D/A 1 primary_doc.xml X0708 D/A LIVE 0001991732 Cantai Therapeutics, Inc. 3675 MARKET STREET SUITE 200 PHILADELPIA PA PENNSYLVANIA 19104 603-996-1218 DELAWARE None None Corporation true 2023 Errik Anderson 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Geeta Vemuri 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Ross Leimberg 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Joshua Brandt 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Biotechnology Decline to Disclose 06b true 0001991732-23-000001 2023-11-06 false true false 0 3000000 700000 2300000 false 3 0 0 0 false Cantai Therapeutics, Inc. Errik Anderson Errik Anderson President 2023-11-20